Live Breaking News & Updates on Perspective Therapeutics Company Profile

Stay updated with breaking news from Perspective therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Perspective Therapeutics, Inc. (NYSE:CATX) Given Average Recommendation of "Buy" by Brokerages

Perspective Therapeutics, Inc. (NYSE:CATX – Get Free Report) has been given a consensus rating of “Buy” by the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six analysts have rated the stock with a buy rating. The average 1 year price target among brokerages that have issued ratings on the stock in […] ....

York Mellon Corp , Investment Counsel Inc , Royal Bank , Cantor Fitzgerald , Advisory Group , Bleakley Financial Group , Perspective Therapeutics Inc , Lantheus Alpha Therapy Llc , Securities Exchange Commission , Simplicity Wealth , Perspective Therapeutics Company Profile , Perspective Therapeutics , Get Free Report , Marketbeat Ratings , Lantheus Alpha Therapy , Exchange Commission , Financial Group , New York Mellon Corp , Get Free , Perspective Therapeutics Daily ,

Perspective Therapeutics (NYSEAMERICAN:CATX) Trading Down 7.2%

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report) fell 7.2% during mid-day trading on Tuesday . The stock traded as low as 1.42 and last traded at 1.42. 4,018,949 shares traded hands during trading, an increase of 8% from the average session volume of 3,734,385 shares. The stock had previously closed at 1.53. Analyst Upgrades […] ....

Markus Puhlmann , Securities Exchange Commission , Perspective Therapeutics Company Profile , Perspective Therapeutics Inc , Taylor Morgan Wealth Management , Lantheus Alpha Therapy Llc , Perkins Capital Management Inc , Vanguard Group Inc , Hightower Advisors , York Mellon Corp , Perspective Therapeutics , Get Free Report , Therapeutics Trading Down , Lantheus Alpha Therapy , Exchange Commission , Capital Management , Tower Advisors , Morgan Wealth Management , New York Mellon Corp , Perspective Therapeutics Daily ,

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Director Purchases 16,170.24 in Stock

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report) Director Robert F. Williamson III bought 25,266 shares of the stock in a transaction dated Monday, January 29th. The stock was acquired at an average price of 0.64 per share, with a total value of 16,170.24. Following the completion of the purchase, the director now owns 211,555 […] ....

United States , Robertf Williamson , Perkins Capital Management Inc , Wealth Effects , Taylor Morgan Wealth Management , Perspective Therapeutics Inc , Perspective Therapeutics Company Profile , Vanguard Group Inc , Perspective Therapeutics , Get Free Report , Director Robert , Capital Management , Morgan Wealth Management , Creative Planning , Perspective Therapeutics Daily , Nyseamerican Catx , Insider Trading , Nsider Trades ,

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Insider Purchases 140,000.00 in Stock

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report) insider Markus Puhlmann acquired 280,000 shares of the stock in a transaction on Wednesday, January 24th. The shares were acquired at an average price of 0.50 per share, with a total value of 140,000.00. Following the purchase, the insider now owns 1,375,425 shares in the company, valued […] ....

United States , Markus Puhlmann , Perspective Therapeutics Inc , Wealth Effects , Charles Schwab Investment Management Inc , York Mellon Corp , Securities Exchange Commission , Taylor Morgan Wealth Management , Perspective Therapeutics Company Profile , Perspective Therapeutics , Get Free Report , Exchange Commission , Schwab Investment Management , New York Mellon Corp , Morgan Wealth Management , Perspective Therapeutics Daily , Nyseamerican Catx , Insider Trading , Nsider Trades ,

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Director Robert F. Williamson III Buys 22,134 Shares of Stock

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report) Director Robert F. Williamson III acquired 22,134 shares of the company’s stock in a transaction on Thursday, January 25th. The stock was purchased at an average cost of 0.49 per share, for a total transaction of 10,845.66. Following the completion of the transaction, the director now owns […] ....

United States , Robertf Williamson , York Mellon Corp , Perspective Therapeutics Inc , Charles Schwab Investment Management Inc , Taylor Morgan Wealth Management , Wealth Effects , Perspective Therapeutics Company Profile , Perspective Therapeutics , Get Free Report , Director Robert , Schwab Investment Management , New York Mellon Corp , Morgan Wealth Management , Perspective Therapeutics Daily , Nyseamerican Catx , Insider Trading , Nsider Trades ,